Navigation Links
NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace
Date:6/18/2014

A collaboration between the National Science Foundation (NSF) and the National Institutes of Health will give NIH-funded researchers training to help them evaluate their scientific discoveries for commercial potential, with the aim of accelerating biomedical innovations into applied health technologies.

I-Corps at NIH is a pilot of the NSF Innovation Corps (I-Corps) program specially tailored for biomedical research. Academic researchers and entrepreneurs with Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) Phase I awards awards that establish feasibility of proof of concept for commercializable technology from participating NIH institutes will be eligible to apply to I-Corps at NIH. NIH will begin outreach to the small business research community with a June 25 program briefing at the 2014 BIO International Convention in San Diego, and a webinar on July 2.

The I-Corps Teams curriculum is a nine-week boot camp in which experienced business-savvy instructors work closely with teams of researchers to help them explore potential markets for their federally funded innovations. I-Corps instructors take a scientific method-based approach to customer discovery that resonates with scientists and engineers. While I-Corps instructors typically have a wide range of expertise, I-Corps at NIH will be taught by instructors who have biomedical business experience.

Providing tools for prospective entrepreneurs

The NIH institutes that will participate in the pilot program are the National Cancer Institute, the National Heart, Lung and Blood Institute, the National Institute of Neurological Disorders and Stroke, and the National Center for Advancing Translational Sciences.

Michael Weingarten, director of the NCI SBIR Development Center, said he and his colleagues initially reached out to NSF because they witnessed the difference I-Corps made for the graduates. To date, more than 300 three-person teams have completed the NSF I-Corps training, including those supported by the Department of Energy's Advanced Research Projects Agency.

"I-Corps will help teach NIH-funded start-ups how to build scalable business models around new technologies they're developing for the detection and treatment of disease. The program sheds new light on how companies can deal with important business risks such as protecting intellectual property, and developing regulatory and reimbursement strategies," Weingarten said.

I-Corps will supplement SBIR/STTR awardees' scientific skills through real time interactions with over 100 potential customers to validate their technology's market potential. The 24 selected teams will receive supplemental funding from NIH to support entrepreneurial training, mentorship and collaboration opportunities.

"This new collaboration with NIH is further evidence of the flexibility and efficacy of the I-Corps model," said Pramod Khargonekar, NSF assistant director for engineering. "Translating basic biomedical research to the marketplace has its own particular set of challenges, which we recognize. By focusing and adapting the I-Corps curriculum to the life sciences, we expect biomedical researchers will be better-equipped to enter the business arena."

NIH awards more than $700 million in SBIR/STTR research and development awards each year. "This pilot will leverage NIH's robust SBIR/STTR program and further NIH's mission to advance our understanding of human illness and treatment of disease and disability," said NIH SBIR/STTR program coordinator Matthew Portnoy. "We look forward to this collaborative endeavor with NSF."

A sustainable innovation ecosystem

The I-Corps network continues to undergo strategic expansion.

In addition to the pilot, existing NIH-funded programs can apply to become new NSF I-Corps sites to broaden the I-Corps network. These programs include the NIH Centers for Accelerated Innovation and Research Evaluation and Commercialization Hubs, which focus on academic researchers with technologies that have not yet led to the formation of a startup or have been licensed by an existing company.

All people and organizations involved in I-Corps become part of the NSF-established National Innovation Network, a nationwide web created to leverage the community that has developed among the grantees to increase the program's impact.

NCI will lead outreach to the small business community in coming weeks, beginning with a briefing on the program at the 2014 BIO International Convention, the world's largest gathering of the biotechnology industry, on June 25 from 2-3 p.m. PDT in San Diego and a webinar on July 2. Steve Blank, a serial entrepreneur and academic who developed the original course which I-Corps is based on, will participate in both events.


'/>"/>

Contact: NIH National Cancer Institute Office of Communications
ncipressofficers@mail.nih.gov
301-496-6641
NIH/Office of the Director
Source:Eurekalert

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. BGI and Aspera collaborate on high-speed data exchange to advance genome research
3. Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
4. USDA scientists collaborate with global researchers to advance the mapping of the barley genome
5. ALS TDI and Gladstone Institutes collaborate to discover potential ALS treatments
6. Springer will collaborate with the Italian Society for Ultrasound in Medicine and Biology
7. Springer to collaborate with Scion on open access journal
8. Feinstein Institute collaborates with GSK, UPenn, MIT to research bodys electrical impulses
9. OU researchers collaborate on $20 million NSF EPSCoR grant
10. TabletKiosk and SMI Collaborate to Produce the Sahara EyeSlate
11. NJIT professor collaborated on new federal report on Deepwater Horizon oil spill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2019)... ... January 14, 2019 , ... CellMax Life , a ... blood, will present new findings at the ASCO Gastrointestinal Cancer Symposium in San ... results from this study show CellMax Life’s blood test, based on its proprietary ...
(Date:1/10/2019)... ... January 10, 2019 , ... ... translational gap between inexpensive in vitro studies and significantly more expensive in vivo ... vivo efficacy and toxicity. To address this need, researchers have begun to adopt ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... (RWD) and Artificial Intelligence solutions for precision health in oncology and other key ... J.P Morgan’s exclusive meeting of investors, entrepreneurs and executives spanning the entire healthcare ...
Breaking Biology News(10 mins):
(Date:1/20/2019)... ... January 16, 2019 , ... On January 15 of this year, ... by Asymmetrex director James L. Sherley, M.D., Ph.D. The PGCB was ... the PGCB and CellTrials.org. Now in its 21st year of operation, the PGCB ...
(Date:1/20/2019)... LOUISVILLE, Ky. (PRWEB) , ... January 17, 2019 ... ... and an Autodesk Platinum Partner announces the launch of a specialized automation technology, ... customer requested parameters for automatic generation of models and drawings to deliver to ...
(Date:1/15/2019)... ... January 15, 2019 , ... With the U.S. Congress designating January as Cervical ... (STD) testing service, today announces tips to help reduce the risk of Cervical Cancer. , ... (HPV). Genital HPV is the #1 most common STD and an STI that ...
(Date:1/10/2019)... ... 2019 , ... Rascal was adopted from a local shelter when he was around two years ... Unfortunately, just six weeks after he was adopted, he tore his right cruciate ligament. ... the joint after such a traumatic injury. , Sure enough, when Rascal was about nine ...
Breaking Biology Technology: